#

Small caps

: 1296
Regulators have agreed to review Biohaven’s application for approval of an experimental treatment for a rare disease that causes a gradual loss of muscle control / Photo: Facebook / Biohaven
Small Caps·
Biohaven soars 25% as drug moves closer to approval. Is there more upside?
Park Aerospace produces composite materials used in structures for jet engines, civilian and military aircraft, drones, and helicopters / Photo: LinkedIn / Park Aerospace Corp.
Small Caps·
Defense stocks are sliding despite rising orders. What should investors do?
Lycia shares will trade on the Nasdaq under the ticker LYCA / Photo: X / Lycia Therapeutics
Small Caps·
Lycia IPO: Food allergy biotech cofounded by Nobel laureate debuts on the Nasdaq
Archer Aviation, valued at around $3 billion, is developing vertical takeoff and landing air taxis / Photo: www.archer.com
Small Caps·
Motley Fool: Six next-generation tech stocks not to forget amid the Anthropic IPO
Ken Griffin’s Citadel manages $77 billion, according to company data as of October 1 / Photo: Erlin Diah / Shutterstock.com
Small Caps·
AI needs power and computing capacity: Three Griffin holdings with up to 400% upside
Braze helps marketers to deepen customer relationships, responding to customer behavior in real time to coordinate personalized experiences across channels, the Journal notes / Photo: Instagram / Braze
Small Caps·
Software maker Braze soars 50% as Salesforce agrees to buy it for $5.66 bln
Penguin supplies server memory modules and builds and operates AI computing systems / Photo: www.penguinsolutions.com
Small Caps·
Memory stocks plunged as much as 25% last week. How to buy the dip.
Veradermics’ drug could become the first FDA-approved nonhormonal pill for male pattern hair loss, which affects around 50 mln men in the U.S. / Photo: Studio Romantic / Shutterstock
Small Caps·
Veradermics jumps on successful trial of its hair-loss pill. Is the stock a buy?
Disc stock jumped 39% after a successful trial for its drug bitopertin, its best day since late 2022 / Photo: www.discmedicine.com
Small Caps·
Disc Medicine has best day in 4 years as its blood-disorder drug succeeds in trial
The deal comes after Silence Therapeutics reported positive results for its experimental blood cancer medicine / Photo: Kittyfly / Shutterstock
Small Caps·
Silence Therapeutics soars 125% as Merck to acquire developer of blood cancer drug
Brady stock is up more than 13% year to date, and analysts see around 35% further upside / Photo: www.bradycorp.com
Small Caps·
Analysts see 35% upside in label maker Brady on data center demand and Honeywell deal
Victoria’s Secret is up more than 60% year to date and around 180% over the last 12 months / Photo: Instagram / victoriassecret
Small Caps·
Needham makes case for obesity drugs as long-term catalyst for Victoria’s Secret
Load more